- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: OncoTarget, 10.2019, Nr. 46, S. 4721-4723, doi:10.18632/oncotarget.27094
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2019
- Urheber
-
Ronellenfitsch, Michael Wilfried
Luger, Anna-Luisa
Steinbach, Joachim Peter
- URN
-
urn:nbn:de:hebis:30:3-507611
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ronellenfitsch, Michael Wilfried
- Luger, Anna-Luisa
- Steinbach, Joachim Peter
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2019
Ähnliche Objekte (12)
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets
New therapeutic targets in rheumatoid arthritis
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets
New therapeutic targets in rheumatoid arthritis
SUMOylation in glioblastoma : a novel therapeutic target
Therapeutic Potential of Selenium in Glioblastoma
Neurotransmitters: potential targets in glioblastoma
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
mTOR inhibitors : initial therapeutic experience in pediatric organ transplant recipients
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
The macrophage as therapeutic target
Altersabhängige Expression von p53, MDM2, EGFR und MSH2 im Glioblastoma multiforme
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Aspartic acid proteases as therapeutic targets